Skip to main content

Find Clinical Trials

Home
Conditions
Hyperuricemia

Clinical trial condition

Hyperuricemia

Explore clinical trials studying Hyperuricemia. Study availability and eligibility vary by location and protocol.

167 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hyperuricemia trial results

Completed

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

NCT02078219

Conditions: Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +13 more
Locations: Research Site Chofu-shi, Japan

Research Site Fukuoka, Japan

Research Site Fukuoka, Japan

Research Site Fukuoka, Japan

View all 14 locations

View Trial Details

Completed

A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

NCT03316131

Conditions: Arthritis, Asymptomatic Hyperuricemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Research Site Glendale, California, United States

Research Site Baltimore, Maryland, United States

View Trial Details

Completed

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

NCT03185793

Conditions: Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Jiangsu Hengrui Medicine Co., Ltd. Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

NCT02600780

Conditions: Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Dow University of Health Sciences Karachi, Sindh, Pakistan

View Trial Details

Completed

Compare the Renal Protective Effects of Febuxostat and Benzbromarone

NCT02338323

Conditions: Abnormal Renal Function, Chronic Disease, Chronic Kidney Disease, +12 more
Locations: Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients

NCT02338128

Conditions: Disorders Associated With Peritoneal Dialysis, Hyperuricemia, Pathologic Processes, +1 more
Locations: Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Genetics of Hyperuricemia Therapy in Hmong

NCT02371421

Conditions: Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +13 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases

NCT02905448

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +22 more
Locations: Not specified

View Trial Details

Completed

Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

NCT02500641

Conditions: Arthritis, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Medizinische Klinik und Poliklinik III/Rheumatologie Universitätsklinikum "Carl Gustav Carus" Der Technischen Universität Dresden, Germany

Presidio Ospedaliero San Filippo e Nicola Università degli Studi dell'Aquila U.O.C Geriatria e Lungodegenza Geriatrica Avezzano, L'Aquila, Italy

Ospedale San Salvatore U.O.C. Medicina Interna e Nefrologia Dipartimento MeSVA Università degli Studi dell'Aquila Coppito, L'Aquila, Italy

Azienda Ospedaliero-Universitaria Policlinico Sant'Orsola-Malpighi Bologna, Italy

View all 26 locations

View Trial Details

Completed

Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

NCT03921736

Conditions: Cardiovascular Diseases, Hypertension, Hyperuricemia, +4 more
Locations: Not specified

View Trial Details